Events Test

Non-Academic MHRT/C Domain 8 (virtual) | June 1, 2, 5, ...

June 6 & 8, 2023, 9:00 am to 12:15 pm | 6 Contact Hours | Zoom Topic: Assessing Skills and Self-Evaluation This 2-day, 6-hour training is intended to partially fulfill the initial 24 hours of training requirements for Certified Clinical Supervisor (CCS). ...

Presenter: Elizabeth Fowlie Mock, MD, MPH | Description: A tour of the many tools to assist prescribers with evaluating risks and benefits of controlled substance prescribing, and particularly those to assess for higher-risk prescribing practices. ...

June 13 & 15, 2023, 9:00 am to 12:15 pm | 6 Contact Hours |  Zoom Topic: Professional Development This 2-day, 6-hour training is intended to partially fulfill the initial 24 hours of training requirements for Certified Clinical Supervisor (CCS) ...

June 20 & 22, 2023, 9:00 am to 12:15 pm | 6 Contact Hours |  Zoom Topic: Effective Management and Administration This 2-day, 6-hour training is intended to partially fulfill the initial 24 hours of training requirements for Certified Clinical Supervisor (CCS) ...

June 27 & 29, 2023, 9:00 am to 12:15 pm | 6 Contact Hours |  Zoom Topic: Professional Responsibility and Ethics This 2-day, 6-hour training is intended to partially fulfill the initial 24 hours of training requirements for Certified Clinical Supervisor (CCS) ...

Presenter: R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM | Description: The revised 2023 Fourth Edition of The ASAM Criteria is soon to be released. This webinar will provide a high level overview of the changes to The ASAM Criteria, how it has been adapted and how it will be evaluated. ...

July 19, 21, 25, 28, & 31 | 8:30 am to 11:45 and 1:45 to 5:00pm | 30 hours | $250 (scholarship available for rural participants)| Non-academic MHRT/C Course ...

Presenter: Jed Nitzberg, DEA Investigator | Description: This webinar, presented from the perspective of the DEA, will review your responsibilities regarding security, prevention of diversion, and recordkeeping as a DEA registrant. Tips on ways to reduce the chances of drug diversion and fraudulent prescribing will be shared to prevent costly regulatory issues from occurring in your practices. Finally, you will learn what to expect when the DEA visits your practice. ...